R&D Projects 2018-07-10T09:41:25+00:00

R&D Projects

Alpex Pharma has undertaken extensive development activities for third parties.

Contact us

Alpex Pharma identifies product opportunities and develops them internally in view of finding interested licensing partners.
Our development plan include drug-excipient compatibility studies, analytical method development, definition of formula, cleaning development, non-pivotal stability studies and reporting.

Projects currently under developement

Drug category:
Mucolythic
Prescription:
OTC
Dosage form:
Effervescent tablets
License granted:
Available
Indication:
Cold and Cought
Free available territories:
Worldwide
Drug category:
NSAID
Prescription:
RX
Dosage form:
ODT
License granted:
Few EU & Asian Counties
Indication:
Artritis Reumatoide
Free available territories:
Rest of the world
Drug category:
Benzodiazepine
Prescription:
RX
Dosage form:
ODT
License granted:
USA
Indication:
Seizure Disorders & Panic Disorders
Free available territories:
Rest of the world
Drug category:
Narcotic
Prescription:
RX
Dosage form:
ODT
License granted:
USA
Indication:
Breakthrough Pain (buccal)
Free available territories:
Rest of the world
Drug category:
Minerals & Vitamins
Prescription:
OTC
Dosage form:
Effervescent tablets
License granted:
EU
Indication:
Osteoporosis
Free available territories:
Free Territories
Drug category:
Mucolythic
Prescription:
RX
Dosage form:
Effervescent tablets
License granted:
License
Indication:
Cold and Cought
Free available territories:
Free Territories
Drug category:
Narcotic
Prescription:
RX
Dosage form:
Effervescent tablets
License granted:
EU
Indication:
Pain Killer
Free available territories:
Free Territories
Drug category:
Minerals & Vitamins
Prescription:
OTC
Dosage form:
Sachet
License granted:
EU
Indication:
Osteoporosis
Free available territories:
Free Territories

More Information

Contact our staff for more information about
R&D Project of Alpex Pharma

CONTACT US